Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Jiankangyuan subsidiary wins "2020 Guangdong Provincial Intellectual Property Demonstration Enterprise"
Published Time：
2020-12-15
On December 11, the Guangdong Intellectual Property Protection Association issued a notice on the identification of "2020 Guangdong Provincial Intellectual Property Demonstration Enterprises." Shenzhen Tai Tai Pharmaceutical Co., Ltd. (hereinafter referred to as "Tai Tai Pharmaceutical"), a subsidiary of Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan Group"), was recognized as a "2020 Guangdong Provincial Intellectual Property Demonstration Enterprise" based on its excellent independent innovation capabilities and sound intellectual property management system, after passing the strict review by the expert panel.
(Screenshot from the official website of the Guangdong Intellectual Property Protection Association)
It is understood that the evaluation of "Guangdong Provincial Intellectual Property Demonstration Enterprises" is a reward and encouragement identification form formulated by the local government for implementing the intellectual property strategy, promoting the construction of a strong province in intellectual property and innovative Guangdong, accelerating the transformation of economic development methods, and enhancing the independent innovation capabilities and core competitiveness of enterprises. Applicant enterprises need to undergo a review by Guangdong provincial intellectual property experts under the guidance of the Guangdong Provincial Intellectual Property Office. This review assesses multiple aspects of the enterprise, including intellectual property management and application capabilities, independent innovation capabilities, and market competitiveness. Only enterprises that pass the review can obtain this title. Those that pass serve as leaders in regional intellectual property development, providing strong support for local intellectual property development.
Local governments have continuously strengthened their support for intellectual property advantage enterprises: increasing investment, securing special funds, gathering expert resources and support measures, and focusing on targeted supervision of enterprises' intellectual property work. These measures fully demonstrate the incentive role of the intellectual property system in promoting innovation and enhancing economic competitiveness. Tai Tai Pharmaceutical has significant advantages in scientific research strength, production technology, and product quality. As an excellent enterprise in the pharmaceutical field of Shenzhen, Tai Tai Pharmaceutical's recognition as a "2020 Guangdong Provincial Intellectual Property Demonstration Enterprise" is also authoritative affirmation of Health Yuan Group's consistent emphasis on independent technological research and development and the in-depth implementation of its intellectual property strategy.
Over the years, under the leadership of Chairman Zhu Baoguo, Health Yuan Group has established a solid and comprehensive intellectual property management system and attaches great importance to the research and development and innovation of pharmaceutical technologies, having obtained numerous intellectual property rights. At the same time, relying on its strength and experience in the greater health field, the company continuously develops pharmaceutical technologies with independent intellectual property rights. It has now developed into a pharmaceutical group with strong comprehensive strength in China, and its business covers many sectors, including chemical preparations, raw materials, traditional Chinese medicine, health products, OTC, and diagnostic reagents.
Tai Tai Pharmaceutical's recognition as a "2020 Guangdong Provincial Intellectual Property Demonstration Enterprise" is a high degree of recognition by authoritative institutions of Health Yuan Group's independent research and development capabilities, intellectual property protection capabilities, and future market development potential. It also marks a new stage for the group in intellectual property construction and management. In the future, Health Yuan Group will continue to increase investment in scientific research, focus on core technology research and development, improve relevant intellectual property protection mechanisms, and strengthen the transformation of scientific research results. While consolidating and enhancing its own core competitive advantages, it will also promote the innovative development of the Shenzhen pilot demonstration zone.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.